Aldeyra Therapeutics, Inc.

ALDX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 10, 2021 FORM 4 SUBMISSION
4 Jun 10, 2021 FORM 4 SUBMISSION
4 Jun 10, 2021 FORM 4 SUBMISSION
4 Jun 10, 2021 FORM 4 SUBMISSION
4 Jun 10, 2021 FORM 4 SUBMISSION
4 Jun 10, 2021 FORM 4 SUBMISSION
8-K Jun 9, 2021 8-K
10-Q May 6, 2021 10-Q
8-K May 6, 2021 8-K
4 May 4, 2021 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
424B5 Apr 29, 2021 424B5
8-K Apr 29, 2021 8-K
424B5 Apr 27, 2021 424B5
8-K Apr 27, 2021 8-K
8-K Apr 21, 2021 8-K
EFFECT Apr 15, 2021
4 Apr 14, 2021 FORM 4 SUBMISSION
4 Apr 14, 2021 FORM 4 SUBMISSION
4 Apr 14, 2021 FORM 4 SUBMISSION
DEFA14A Apr 14, 2021 DEFA14A
DEF 14A Apr 14, 2021 DEF 14A
CORRESP Apr 13, 2021
UPLOAD Mar 17, 2021
S-3 Mar 11, 2021 S-3
S-8 Mar 11, 2021 S-8
← Newer Page 10 of 26 · 646 filings Older →